SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ajanta Pharma informs about board Meeting

12 Jun 2014 Evaluate

Ajanta Pharma has informed that a meeting of the Board of Directors of the company will be held on June 13, 2014, for considering appointment of two Additional Directors of the company.

The above information is a part of company’s filings submitted to BSE.

Ajanta Pharma Share Price

3253.70 64.85 (2.03%)
24-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1874.70
Dr. Reddys Labs. 1328.35
Cipla 1437.35
Zydus Lifesciences 1099.10
Lupin 2367.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: